hospital stay News
-
Radar Vest Could Help Patients With Congestive Heart Failure Reduce Hospital Visits
There might be some good news for the nearly six million Americans with congestive heart failure. Those patients are often in and out of hospitals because their lungs fill with fluid. But as CBS2’s Dr. Max Gomez reports, a new device – a “radar vest” – could prevent those hospital ...
-
High-tech vest may help heart failure patients avoid hospital stays
When people with congestive heart failure feel short of breath and fatigued, it means their lungs are slowly filling with fluid. But by the time they feel those symptoms, they may need hospitalization to correct the ...
-
Velano Vascular Named Top Impact Company for 2021 by Real Leaders
Vascular access technology pioneer Velano Vascular was today named a Top Impact Company for 2021 by Real Leaders, the world’s first business and sustainable leadership magazine. Velano was recognized alongside such notable brands as Tesla, Beyond Meat, and Patagonia on the 2021 list for its work making hospital stays more humane and less risky for both patients and practitioners. Through ...
-
Microsure live at WSRM2022 in Cancun
Microsure will be present at #WSRM2022 in Cancun, Mexico. Come and visit us at booth 8 (1-4 June) to learn about our newest generation microsurgical robot. Update: After a year of absence due to the pandemic, the World Society of Reconstructive Microsurgery could celebrate its 11th Congress in Cancun from 1-4 June 2022. Microsure was present for the second time and provided a sneak ...
-
iRhythm builds case for wearable cardiac monitor with data in fainting, TAVR patients
iRhythm Technologies has presented new data on its Zio wearable cardiac monitoring device at the American College of Cardiology (ACC) 71st Annual Scientific Session & Expo, building the clinical case for its devices. One study used Zio AT for monitoring patients who were taken to hospital after fainting. By using the device to monitor patients after discharge, the physicians reduced ...
-
FDA Grants Saranas DeNovo Designation for the Early Bird® Bleed Monitoring System
Saranas Inc., a medical device company with innovative technology for real-time detection and monitoring of internal bleeding during endovascular procedures, today announced that it has been granted de novo classification by the U.S. Food and Drug Administration (FDA) for the Early Bird Bleed Monitoring System. According to a recent study of over 17,000 large-bore transcatheter interventions ...
-
SoundBite Medical Solutions is the recipient of the 2020 “National Award for an Engineering Project or Achievement” by Engineers Canada
SoundBite Medical Solutions Inc. (SBMS) today announced that it was granted by Engineers Canada, the national organization of the 12 provincial and territorial associations that regulate the practice of engineering in Canada, the 2020 “National Award for an Engineering Project or Achievement”. The awards acknowledge exemplary community and professional involvement, contributions to ...
-
FDA 510(k) Clearance
ENvizion Medical announced that the ENvue™ Electromagnetic Feeding Tube Placement System and ENvizion Feeding Tubes received FDA 510(k) clearance. This new generation of electromagnetic placement technology addresses current technological limitations and meets the growing clinical need for accurate feeding tube placement at bedside. Globally, over 22 million nasal feeding tubes are placed ...
-
Winner at the 2020 Med-Tech Awards - Numedico
It is with pleasure that we can announce that Numedico Technologies has been nominated as a winner in the 2020 Global Med-Tech Awards. Announced this week, Global Health and Pharma Magazine published the results of the 3rd annual MedTech Awards. This year the GHP News Medtech Awards 2020, celebrated those who have demonstrated an ability to innovate in this industry. Shining in this dynamic ...
-
dBMEDx™ , Inc. Closes Round of Funding, Selected for Venture Showcase
dBMEDx™ , Inc., a privately-held, wireless medical device company, announces the closing of a capital raise of $1.3 million through the sale of common stock, the company’s third successful capital raise. In addition, the company announces that it has been selected to present at the Colorado BioScience Association’s 2014 BioWest Venture Showcase on September 10. The proceeds ...
By dBMEDx
-
Kurin, Inc. announces UK clinical study results showing significant decrease in blood culture contaminations with the Kurin Lock™
Kurin Inc., the inventor and manufacturer of 510(k)-cleared Kurin® blood culture collection sets, announced today a new clinical study supporting the efficacy of their blood culture collection product. Authors from Guy’s and St. Thomas’ NHS Foundation Trust, a prestigious London-based hospital, presented their data at the recent Infection Prevention Society conference in ...
By Kurin, Inc.
-
Abionic launches first Covid-19 severity test to triage patients quickly and accurately
Abionic SA, a Swiss Medtech firm based in Lausanne, has developed the cSOFA score, a tool to assess the severity of Covid-19. The cSOFA score (Covid Sequential Organ Failure Assessment) measures the likelihood of clinical deterioration in Covid-19 patients, enabling triage and assignment to the general ward or intensive care units (ICU) upon admission and during the patients’ hospital stay. ...
By Abionic SA
-
1st Patient treated with Vetex Thrombectomy Catheter
Vetex™ Medical Ltd., an innovator in deep vein thrombosis (DVT) treatment, announced it’s first patient on December 18th, 2018, treated in the VETEX (Venous Thrombus Extraction) Study, a first-in-man, multicenter study of the Vetex™ Thrombectomy Catheter. The Vetex device is the first DVT device to combine rotational and grasping action to quickly and gently remove large volumes ...
-
Kurin, Inc. Announces Launch of Its Proprietary Push-button Needle System
Kurin, Inc., the inventor and manufacturer of the Kurin® blood culture collection sets announced that they have commenced the commercial launch of their push-button needle, to be used as part of Kurin blood culture sets. The Advance Safety Needle System was tested in 2021 and is now being sold into accounts using Kurin. “We are proud to commercialize the Advance Safety Needle, as there ...
By Kurin, Inc.
-
Saranas® Awarded Multiple Purchasing Contracts with Large Healthcare Systems
Saranas announces today the closing of the company’s two largest Integrated Delivery Network (IDN) contracts and agreements signed to date: CommonSpirit Health and the Department of Defense. CommonSpirit Health, encompassing all Catholic Health Initiative (CHI) and Dignity Health hospitals, has awarded Saranas a multi-year contract for the use of the Early Bird® Bleed Monitoring System ...
-
CardioWise, Inc. Named a Top-Ten Finalist in Best Cardiovascular Digital Diagnostic Category by UCSF Health Hub
The University of California San Francisco (UCSF) Health Hub has selected CardioWise, Inc. a Digital Health Awards 1st Round (Top Ten) Finalist in its Best Cardiovascular Digital Diagnostic category. The goal of UCSF Digital Health Awards was to select companies that promote faster, better, more cost-effective healthcare by improving outcomes such as shorter hospital stays, reduced patient and ...
-
Noah Medical Announces New Research and Training Facilities for Next Generation Medical Robotics Platforms
The company, founded by medical robotics entrepreneur Jian Zhang, will use these state-of-the-art facilities to pursue disruptive new medical robotics indications left unaddressed by current platforms. “We envision a world in which next generation medical robots help diagnose disease and treat patients early to ensure minimal hospital stays and quick recoveries,” said Zhang, Noah ...
By Noah Medical
-
Microbial Outbreak Results in Deaths at Neonatal Intensive Care Unit
Cinnaminson, NJ, August 8th, 2012 The Health Minister of the Bahamas recently ordered an investigation into an outbreak of a microbial pathogen at a neonatal intensive care unit. The outbreak, caused by a type of bacteria known as Acinetobacter baumannii, is believed to have sickened eight infants and caused two of the infants to die. Outbreaks of Acinetobacter baumannii in healthcare ...
-
Lung Therapeutics, Inc. Raises $36 Million in Series C Financing to Advance Clinical Pipeline
Lung Therapeutics, Inc., a clinical stage biopharmaceutical company developing novel therapeutics for orphan, pulmonary indications, announced today the closing of $36 million Series C financing. To date, Lung Therapeutics has raised a total of $53 million in outside funding. The Series C funding will finance the company’s next stage of growth, including the advancement and completion of ...
-
Coala Life in collaboration with Region Gävleborg, Sweden, to run the TITAN-DM study on 500 patients with diabetes
Stockholm, October 7, 2021: Coala Life, a leading company in cloud-based remote monitoring of heart and lung diseases, is now conducting a clinical observational study in collaboration with researchers at the Gävleborg Region, Uppsala University and Karolinska Institute to increase knowledge about the incidence of atrial fibrillation in people with diabetes. The TITAN-DM study is expected to ...
Need help finding the right suppliers? Try XPRT Sourcing. Let the XPRTs do the work for you